Sandboxing, demonstrated value, and a hard line at clinical judgment: a physician-researcher’s three-question test before AI touches a trial.
- Inside The Rush To Accelerated Approval: A Consultant's View
- Why Virtua Health's AI Committee Gives IT The Review, Not The Vote
- Building Effective, Retrospective Decision-Grade Disease Registries
- To Pick The Right Medical LLM, First Assess Your Readiness
- Clinical Trial Tech Fails On Systems, Not Software
- Inside A Sponsor-Site Relationship That Actually Worked
- Real-World Data Won't Replace Trials. Here's Its Real Job
- Inside Virtua Health's Pipeline For Anonymizing Trial Imaging Data
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Running Compliant Studies Without Enterprise EDC Overhead
Low-complexity medical device and IVD studies often fall between enterprise EDC systems and spreadsheets. This webinar shows how a compliant, audit-ready alternative works in practice.
-
eCOA Risk Management In The Digital Age
Regulators across the globe are urging the industry to strengthen their data integrity practices. This article addresses the additional considerations that go hand in hand with the increased reliance on eSource data and the expansion of the electronic systems in clinical trials.
-
Exploring The Potential Of Non-Consumer Smartphones In Clinical Trials
We selected and evaluated a non-consumer device, to explore its potential as a reliable tool for home-based ePRO measure administration. Here’s what we learned from this usability testing.
-
Cytokine Release Syndrome Monitoring
Here we introduce an innovative risk-monitoring solution aimed at mitigating Cytokine Release Syndrome (CRS), a critical complication in immunotherapy that often leads to prolonged hospitalization.
-
Taking eCOA Technology Deployment Off The Critical Path
Consider this expedited review approach to facilitate the efficient evaluation of COAs and eCOAs, streamlining the pathway for successful trial execution.
-
Supporting NASH/NAFLD's Unmet Needs With ePRO
Explore the rising prevalence of NASH/MASH, its debilitating effects, and the urgent need for patient-centric approaches in clinical research.
-
Improving Oncology Trial Experiences & Efficiencies Digital Solutions
Uncover how a top-10 pharmaceutical company was able to overcome oncology clinical study obstacles with a digital software platform.
-
Build Versus Buy: What's The Best Tech Tool For Study Activation?
In the case of study activation, there are several compelling reasons that buying an appropriate purpose-built system is a better choice than taking on the challenge of building a study activation tool.
-
The Beginner's Guide To An Electronic Data Capture (EDC) System
In this blog, delve into a basic understanding of the EDC system and its role in clinical trials.
- A Framework For Deploying AI In Clinical Trials Without The Hype
- Why Younger Clinical Researchers Are More Wary Of AI Than Their Elders
- Inside The Rush To Accelerated Approval: A Consultant's View
- Why Virtua Health's AI Committee Gives IT The Review, Not The Vote
- Clinical Trial Tech Fails On Systems, Not Software
RECENT NEWSLETTERS
- 10.15.26 -- AI, Site Burden, And Vendor Risks Are Testing Trials
- 10.08.26 -- AI, RTSM, And Trial Systems Are Still Breaking Down
- 10.03.26 -- Best Of September: AI, Wearables, And Trial Workflow Gaps
- 10.01.26 -- AI, Data Integrity, And Wireless Gaps Are Reshaping Trials
- 09.24.26 -- AI, Wearables, And CRA Workflows Are Exposing Trial Gaps